Neurodegenerative diseases include Alzheimer's, Schizophrenia and Parkinson's.
In a BSE filing, the company said it has been granted "one product patent from Europe and one product patent from Hong Kong corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases".
Also Read
ALSO READ: Suven gets fresh product patents overseas
With these new patents, Suven has a total of 16 granted patents from Europe and 17 from Hong Kong.
"These patents are exclusive intellectual property of Suven... Products out of these inventions may be out-licensed at various phases of clinical development like at phase-1 and phase-2," Suven Life Sciences said.
Meanwhile, Suven Life Sciences was trading 3.37 per cent up at Rs 291.65 on BSE.